Rox funding Venus's share of development costs (to be repaid interest free through production of gold) is only until a decision to mine is made. Rox and Venus share the pre-production costs 70/30.
Say development costs from 2022 are $20m (just a guess) then Rox needs to raise about another $8m to get to a DFS and decision to mine.
Raising another $8m is not going to bleed Rox dry and if they can produce a good FS the money can be borrowed so there is no more dilution.
Once in production Venus will be repaying Rox about $4m already owed and lost 7$m for the feasibility studies from its share of gold concentrate.
Yes the market does hate the company with a passion and for good reason, Grace/visible gold/ development timeline etc etc.
But RR has made a good start and in time investor confidence may slowly be restored.
My Opinion
- Forums
- ASX - By Stock
- RXL
- Ann: Midway Emerging as a New High-Grade Gold Discovery
RXL
rox resources limited
Add to My Watchlist
1.75%
!
29.0¢

Ann: Midway Emerging as a New High-Grade Gold Discovery, page-25
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.0¢ |
Change
0.005(1.75%) |
Mkt cap ! $212.4M |
Open | High | Low | Value | Volume |
28.5¢ | 29.5¢ | 28.5¢ | $783.8K | 2.745M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 87999 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 0.285 |
1 | 85506 | 0.280 |
2 | 52000 | 0.275 |
12 | 315190 | 0.270 |
3 | 243500 | 0.265 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 27999 | 1 |
0.295 | 106291 | 2 |
0.300 | 128300 | 4 |
0.305 | 144436 | 3 |
0.310 | 60003 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RXL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online